Cargando…

Master regulators of FGFR2 signalling and breast cancer risk

The fibroblast growth factor receptor 2 (FGFR2) locus has been consistently identified as a breast cancer risk locus in independent genome-wide association studies. However, the molecular mechanisms underlying FGFR2-mediated risk are still unknown. Using model systems we show that FGFR2-regulated ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fletcher, Michael N. C., Castro, Mauro A. A., Wang, Xin, de Santiago, Ines, O’Reilly, Martin, Chin, Suet-Feung, Rueda, Oscar M., Caldas, Carlos, Ponder, Bruce A. J., Markowetz, Florian, Meyer, Kerstin B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778544/ https://www.ncbi.nlm.nih.gov/pubmed/24043118 http://dx.doi.org/10.1038/ncomms3464

Ejemplares similares

Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer
por: Meyer, Kerstin B, et al.
Publicado: (2008)

FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness
por: Campbell, Thomas M., et al.
Publicado: (2016)

BaalChIP: Bayesian analysis of allele-specific transcription factor binding in cancer genomes
por: de Santiago, Ines, et al.
Publicado: (2017)

TOX3 Mutations in Breast Cancer
por: Jones, James Owain, et al.
Publicado: (2013)

Genome-driven integrated classification of breast cancer validated in over 7,500 samples
por: Ali, H Raza, et al.
Publicado: (2014)

Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers
por: Callari, Maurizio, et al.
Publicado: (2017)

Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis
por: Sivakumar, Shivan, et al.
Publicado: (2017)

Regulators of genetic risk of breast cancer identified by integrative network analysis
por: Castro, Mauro AA, et al.
Publicado: (2015)

A Prognostic Gene Signature for Metastasis-Free Survival of Triple Negative Breast Cancer Patients
por: Lee, UnJin, et al.
Publicado: (2013)

Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53‐associated features
por: Benor, Gal, et al.
Publicado: (2020)

RedeR: R/Bioconductor package for representing modular structures, nested networks and multiple levels of hierarchical associations
por: Castro, Mauro AA, et al.
Publicado: (2012)

Calling Sample Mix-Ups in Cancer Population Studies
por: Lynch, Andy G., et al.
Publicado: (2012)

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts
por: Callari, Maurizio, et al.
Publicado: (2018)

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
por: Mouron, Silvana, et al.
Publicado: (2021)

High-resolution array CGH clarifies events occurring on 8p in carcinogenesis
por: Cooke, Susanna L, et al.
Publicado: (2008)

Multi-omic machine learning predictor of breast cancer therapy response
por: Sammut, Stephen-John, et al.
Publicado: (2021)

Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast
por: Maia, Ana-Teresa, et al.
Publicado: (2009)

Breast tumor microenvironment structures are associated with genomic features and clinical outcome
por: Danenberg, Esther, et al.
Publicado: (2022)

Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy
por: Campbell, Thomas M., et al.
Publicado: (2016)

Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers
por: Chin, Suet-Feung, et al.
Publicado: (2018)

Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort
por: Mukherjee, A., et al.
Publicado: (2018)

NRG1 fusions in breast cancer
por: Howarth, Karen D., et al.
Publicado: (2021)

Copynumber: Efficient algorithms for single- and multi-track copy number segmentation
por: Nilsen, Gro, et al.
Publicado: (2012)

Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
por: Georgopoulou, Dimitra, et al.
Publicado: (2021)

The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences
por: Pan, Jia-Wern, et al.
Publicado: (2020)

PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes
por: Git, Anna, et al.
Publicado: (2008)

Does massively parallel transcriptome analysis signify the end of cancer histopathology as we know it?
por: Aparicio, Samuel AJR, et al.
Publicado: (2000)

Prognostic Value of MammaPrint(®) in Invasive Lobular Breast Cancer
por: Beumer, Inès J., et al.
Publicado: (2016)

The pitfalls of platform comparison: DNA copy number array technologies assessed
por: Curtis, Christina, et al.
Publicado: (2009)

BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells
por: Khaled, Walid T., et al.
Publicado: (2015)

Posterior Association Networks and Functional Modules Inferred from Rich Phenotypes of Gene Perturbations
por: Wang, Xin, et al.
Publicado: (2012)

Human and mouse oligonucleotide-based array CGH
por: van den IJssel, Paul, et al.
Publicado: (2005)

A Functional Variant at a Prostate Cancer Predisposition Locus at 8q24 Is Associated with PVT1 Expression
por: Meyer, Kerstin B., et al.
Publicado: (2011)

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer
por: Facchinetti, Francesco, et al.
Publicado: (2023)

Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
por: Ali, H. Raza, et al.
Publicado: (2016)

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
por: Curtis, Christina, et al.
Publicado: (2012)

Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses
por: Ng, Pei Sze, et al.
Publicado: (2021)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2020)

Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA
por: Gao, Meiling, et al.
Publicado: (2019)

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer
por: De Mattos-Arruda, Leticia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vsigqp7kupi5jl140cgorh9sba